Development, functional characterization and validation of methodology for GMP-compliant manufacture of phagocytic macrophages: A novel cellular therapeutic for liver cirrhosis.

about

A human iPSC line capable of differentiating into functional macrophages expressing ZsGreen: a tool for the study and in vivo tracking of therapeutic cells.

P2860

Q53968471-2F757575-17BD-4FAF-AC29-48A42538324C

P2860

Development, functional characterization and validation of methodology for GMP-compliant manufacture of phagocytic macrophages: A novel cellular therapeutic for liver cirrhosis.

Item

http://www.wikidata.org/entity/Q41519742

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Development, functional charac ...... erapeutic for liver cirrhosis.

@en

type

Item

label

Development, functional charac ...... erapeutic for liver cirrhosis.

@en

prefLabel

Development, functional charac ...... erapeutic for liver cirrhosis.

@en

P1476

Development, functional charac ...... erapeutic for liver cirrhosis.

@en

P2093

Akib Hamid

http://www.w3.org/2001/XMLSchema#string

Alasdair R Fraser

http://www.w3.org/2001/XMLSchema#string

Anne Atkinson

http://www.w3.org/2001/XMLSchema#string

Audrey Laurie

http://www.w3.org/2001/XMLSchema#string

Chloe Pass

http://www.w3.org/2001/XMLSchema#string

Joanna K Moore

http://www.w3.org/2001/XMLSchema#string

John D M Campbell

http://www.w3.org/2001/XMLSchema#string

Laura Bailey

http://www.w3.org/2001/XMLSchema#string

Marc L Turner

http://www.w3.org/2001/XMLSchema#string

Neil W A McGowan

http://www.w3.org/2001/XMLSchema#string

P2860

Macrophage activation and polarization: nomenclature and experimental guidelines

Establishment and operation of a Good Manufacturing Practice-compliant allogeneic Epstein-Barr virus (EBV)-specific cytotoxic cell bank for the treatment of EBV-associated lymphoproliferative disease.

Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis.

The application of adjuvant autologous antravesical macrophage cell therapy vs. BCG in non-muscle invasive bladder cancer: a multicenter, randomized trial.

Bone marrow injection stimulates hepatic ductular reactions in the absence of injury via macrophage-mediated TWEAK signaling.

Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease.

Lentivirus-induced 'Smart' dendritic cells: Pharmacodynamics and GMP-compliant production for immunotherapy against TRP2-positive melanoma

Phenotypic and functional characterization of macrophages with therapeutic potential generated from human cirrhotic monocytes in a cohort study.

Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis

Modulation of macrophage phenotype by cell shape.

P304

1113-1124

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JCYT.2017.05.009

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Benjamin J Dwyer

Stuart J Forbes

P577

2017-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28673774

http://www.w3.org/2001/XMLSchema#string

P932

5571439

http://www.w3.org/2001/XMLSchema#string

Development, functional characterization and validation of methodology for GMP-compliant manufacture of phagocytic macrophages: A novel cellular therapeutic for liver cirrhosis.

about

P2860

P2860

Development, functional characterization and validation of methodology for GMP-compliant manufacture of phagocytic macrophages: A novel cellular therapeutic for liver cirrhosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932